Glycodelin acts as an immunomodulator in NSCLC and is a predictor of poor prognosis for patients receiving immunotherapy https://www.biorxiv.org/content/10.1101/2023.03.02.530822v1?med=mas
Glycodelin acts as an immunomodulator in NSCLC and is a predictor of poor prognosis for patients receiving immunotherapy https://www.biorxiv.org/content/10.1101/2023.03.02.530822v1?med=mas